开发了一种突变的气溶ACE2,可以在体内中和SARS-CoV-2
Daniel L Kober1, Marley C Caballero Van Dyke2, Jennifer L Eitson2
1Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
mBio
|May 21, 2024
概括
一种经过修改的血管酶转化酶2 (ACE2) 蛋白质可以被雾化,以防止SARS-CoV-2变种. 这种气溶液中的ACE2充当诱受体,抑制病毒感染,并在小鼠中显示出预防性保护作用.
科学领域:
- 病毒学 病毒学
- 蛋白质工程是指蛋白质工程.
- 药物运输 药物运输 药物运输
背景情况:
- SARS-CoV-2 变种需要新的治疗策略.
- 该病毒利用人类的ACE2受体进入细胞.
- 开发诱受体为抗病毒疗法提供了潜在的途径.
研究的目的:
- 为了设计一种具有催化性损害的突变ACE2蛋白质,以实现高效的净化和抗病毒应用.
- 评估气溶液突变ACE2作为预防性治疗SARS-CoV-2感染的疗效.
- 建立一种概念验证,用于在体内以气溶方式输送抗病毒药物.
主要方法:
- 催化受损突变ACE2的设计和特征.
- 在体外抑制试验中,使用隐形病毒载体和传染性SARS-CoV-2的测定.
- 开发一种气溶液输送系统,用于 nebulized ACE2.
- 在K18-hACE2小鼠体内疗效研究.
主要成果:
- 突变ACE2已成功净化,并证明与SARS-CoV-2变种具有广泛的结合性.
- 雾化ACE2保留了病毒结合特性,并在细胞培养物中抑制了病毒感染.
- 在COVID-19的小鼠模型中,突变ACE2的气溶液输送提供了预防性保护.
结论:
- 一种具有催化作用的受损,气溶液中的ACE2蛋白质作为一种有效的诱受体对抗SARS-CoV-2.
- 气溶液输送是一种可行的方法,用于用于呼吸道感染的抗病毒药物.
- 这种工程 ACE2 代表了对抗 SARS-CoV-2 和其他依赖 ACE2 的病毒威胁的有希望的新工具.
相关概念视频
Conjugated Proteins
21.1K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
21.1K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K


